返回期刊详情

Lung Cancer

IF4.4

论文数919

被引数14311

期刊论文 919

发表时间

Changes in HER2 protein expression before and after EGFR TKI therapy in EGFR-mutant non-small cell lung cancer: a real world paired-biopsy study EGFR突变非小细胞肺癌中EGFR TKI治疗前后HER2蛋白表达的变化：一项真实世界配对活检研究

Lung Cancer

IF4.4

2026-10-24

PREAI

Jinyong Kim; Yurimi Lee; Sehhoon Park; Hyun Ae Jung; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Yoon-La Choi; Myung-Ju Ahn

Removal notice to “Characterization of a rare EGFR resistance mutation in a lung cancer patient with a long response to osimertinib: case report” [Lung Cancer 218 (2026) 109489]关于“Characterization of a rare EGFR resistance mutation in a lung cancer patient with a long response to osimertinib: case report” [Lung Cancer 218 (2026) 109489]的撤稿通知

Lung Cancer

IF4.4

2026-10-23

OAAI

Beatriz García-Peláez; Núria Jordana-Ariza; Andrés Aguilar-Hernández; Roger Estrada-Tejedor; Marta Vives-Usano; Mónica Garzón-Ibáñez; Clara Mayo-de-las-Casas; Ruth Román; Rafael Rosell; Miguel Ángel Molina-Vila

Targeting MYC in small cell lung cancer: Bridging molecular subtypes and therapeutic vulnerability 靶向小细胞肺癌中的MYC：连接分子亚型和治疗易感性

Lung Cancer

IF4.4

2026-10-23

OAAI

Caterina De Rosa; Cristina A. Diaz; Juan M. Morillas; Montse Sanchez Cespedes; Carminia Maria Della Corte

Lung cancer associated with cystic airspaces (LCCA): A comprehensive literature review undertaken as part of the British thoracic oncology group (BTOG) work programme 囊性空腔相关肺癌（LCCA）：英国胸科肿瘤学组（BTOG）工作计划中完成的一篇全面文献综述

Lung Cancer

IF4.4

2026-10-23

OAAI

Linda Kimani; Georgia Hyde; Emma OΓÇÖDowd; Christopher Johns; Gerard J. Fitzmaurice; Ashok Kar; Muhammad Majid; Kamalram Thippu Jayaprakash; Anna Sharman; Matthew Evison; Anna Bibby

Severe hepatic injury or immune-related hepatitis? Reconsidering the hepatic safety signal in HBsAg-positive lung cancer 重症肝损伤还是免疫相关肝炎？重新审视HBsAg阳性肺癌患者的肝脏安全性信号

Lung Cancer

IF4.4

2026-10-20

PREAI

Luyun Li; Gang Tian

Integrated histopathological, immunohistochemical, and molecular profiling reveals hidden heterogeneity within histologic subtypes of thymoma 整合组织病理学、免疫组织化学和分子分析揭示胸腺瘤组织学亚型内部的隐藏异质性

Lung Cancer

IF4.4

2026-10-19

PREAI

Yi-Chen Yeh; Min-Shu Hsieh; Lei-Chi Wang; Ping-Yuan Chu; Yu-Chao Wang; Po-Kuei Hsu

Efficacy and safety of primary granulocyte colony-stimulating factor prophylaxis in patients with small-cell lung cancer receiving first-line platinum–etoposide plus a programmed death-ligand 1 inhibitor: A multicenter retrospective observational study 小细胞肺癌患者接受一线铂类–依托泊苷联合程序性死亡配体1抑制剂治疗时，初级粒细胞集落刺激因子预防的疗效与安全性：一项多中心回顾性观察性研究

Lung Cancer

IF4.4

2026-10-19

OAAI

Shuhei Teranishi; Yuki Misumi; Takuma Ishihara; Yuta Yamanaka; Daiki Murata; Tomofumi Hirose; Ryosuke Ochiai; Kento Takagi; Yuko Higashi; Yusuke Hamakawa; Satoshi Ikeda; Naoki Furuya; Yoshiro Nakahara; Satoru Miura; Katsuhiko Naoki

Phase I and early phase II study of enhancing immune checkpoint inhibitor efficacy using a Mycobacterium tuberculosis extract combined with radiation therapy in non-small cell lung cancer patients: NEJ046A I期和早期II期研究：在非小细胞肺癌患者中使用结核分枝杆菌提取物联合放射疗法增强免疫检查点抑制剂疗效：NEJ046A

Lung Cancer

IF4.4

2026-10-18

PREAI

Atsuto Mouri; Jun Sugisaka; Yu Miura; Taku Nakagawa; Akira Kisohara; Hiroshi Wakui; Ryota Kanemaru; Kazuki Katayama; Mika Nakao; Akihiko Miyanaga; Aki Kubota; Satoshi Morita; Masahiro Seike; Makoto Maemondo; Kunihiko Kobayashi

Multi-omics liquid biopsy for leptomeningeal metastases in lung cancer: from molecular mechanisms to precision diagnosis and treatment 肺癌脑膜转移的多组学液体活检：从分子机制到精准诊断和治疗

Lung Cancer

IF4.4

2026-10-17

PREAI

Ruilong Zhang; Qi Zhao; Yue Cao; Shuangshuang Guo; Zhiye Zhang; Haiyang Chen; Qiming Wang

From whole-exome sequencing to functional insight: Characterization of rare germline variants in lung cancer 从全外显子测序到功能见解：肺癌中罕见生殖系变异的特征分析

Lung Cancer

IF4.4

2026-10-14

PREAI

Simone Bonora; Maron Daw; Claudio Tabolacci; Alessio Cortellini; Fabrizio Citarella; Maria Luisa Scattoni; Loredaria Adamo; Anna Marabotti; Carla Lintas; Fiorella Gurrieri

Exosomal miR-3662 originating from M2-polarized macrophages facilitates cisplatin resistance of lung adenocarcinoma cells through inhibiting the IRF8/RASSF5 cascade and boosting autophagy M2极化巨噬细胞来源的细胞外囊泡miR-3662通过抑制IRF8/RASSF5级联并促进自噬，促进肺腺癌细胞对顺铂的耐药性

Lung Cancer

IF4.4

2026-10-14

PREAI

Fengqiang Yu; Jiazhou Xiao; Nanlong Lin; Jianbo Lin; Menglong Zhang; Sizhe Chen; Fancai Lai

Efficacy and safety of adjuvant ensartinib in stage I ALK-positive NSCLC patients: a retrospective, multicenter study 埃苏瑞替尼辅助治疗在Ⅰ期ALK阳性非小细胞肺癌患者中的有效性与安全性：一项回顾性、多中心研究

Lung Cancer

IF4.4

2026-10-09

OAAI

Ziyan Gao; Jian Zheng; Linlin Jia; Wenchao Xia; Yuan Chen; Xiaoping Li; Lin Du; Jing Zhao; Lianmin Zhang; Meng Wang

Lung Cancer

IF4.4

2026-10-08

PREAI

Jingru Luo; Shu Lin; Wenjun Tang; Renhua Guo; Yuecan Zeng

Multicenter case series of pulmonary sclerosing pneumocytoma coinciding with typical carcinoid: Shared AKT1 p.E17K mutation in mixed-growth lesions 多中心病例系列研究：伴有典型类癌的肺硬化性肺细胞瘤，混合生长病灶中共享AKT1 p.E17K突变

Lung Cancer

IF4.4

2026-10-04

PREAI

Weijie Chen; Yongtong Wang; Yue Wang; Runan Zhao; Zhengwei Dong; Yan Huang; Likun Hou; Chunyan Wu; Liye Zhang; Huikang Xie

Lung cytology in the diagnostic workflow: A real-world study of its clinical impact 肺细胞学在诊断工作流程中的临床影响：一项真实世界研究

Lung Cancer

IF4.4

2026-10-03

PREAI

Elisabetta Maffei; Chiara Ciaparrone; Angela D’Ardia; Sara Gaeta; Francesco Sabbatino; Antonio Galderisi; Pio Zeppa; Luka Brcic; Alessandro Caputo

Trial-Specific absolute Disease-Free survival effects of postoperative PD-1/PD-L1 blockade after complete resection of NSCLC: A systematic Review: Absolute DFS with adjuvant PD-1/PD-L1 blockade术后PD-1/PD-L1阻断对完全切除的非小细胞肺癌特定试验绝对无病生存期的影响：一项系统综述：辅助PD-1/PD-L1阻断的绝对DFS

Lung Cancer

IF4.4

2026-10-03

PREAI

Zhiheng Yao; Xinyuan Wang; Hanliang Zhang; Yizhou Huang; Zhenyuan Yang; Chun Chen; Bin Zheng; Hongmu Li

Second-line therapy in extensive-stage small cell lung cancer: an unmet need highlighted by real-world evidence from the LALUCA registry 广泛期小细胞肺癌的二线治疗：LALUCA登记研究中的真实世界证据凸显了这一未满足的需求

Lung Cancer

IF4.4

2026-09-30

OAAI

Daniel Moser; Anna Lang-Stöberl; Hannah Fabikan; Julie Krainer-Jacobs; Oliver Illini; Leyla Ay; Nino Müser; Christoph Weinlinger; Vania Mikaela Rodriguez; Georg-Christian Funk; Marie-Kathrin Breyer; Robab Breyer-Kohansal; Arschang Valipour; Maximilian J. Hochmair

Exploratory analysis of extracellular vesicle Profile changes during pembrolizumab treatment in NSCLC 探索性分析非小细胞肺癌患者接受帕博利珠单抗治疗期间外泌体谱的变化

Lung Cancer

IF4.4

2026-09-29

PREAI

Yuta Hirano; Shigehiro Yagishita; Yuki Shinno; Yasushi Goto; Jun Araya; Yusuke Yamamoto; Yu Fujita

Systemic and intracranial activity of antibody–drug conjugates in patients with non-small cell lung cancer and brain metastases: A systematic review and meta-analysis 抗体药物偶联物在非小细胞肺癌伴脑转移患者中的全身和颅内活性：一项系统评价和 meta 分析

Lung Cancer

IF4.4

2026-09-28

PREAI

Susu Zhou; Jiayi Tan; Vishw Patel; Noriko Kishi; Komal Akhtar; Sam Benjamin; Jade Homsi; Che-Kai Tsao

Real-world progression-free survival with erlotinib versus osimertinib in EGFR L858R + T790M compound mutation non-small cell lung Cancer: An exploratory analysis of the MSK-CHORD dataset EGFR L858R+T790M复合突变非小细胞肺癌患者中使用厄洛替尼与奥希替尼的实时无进展生存比较：MSK-CHORD数据集的探索性分析

Lung Cancer

IF4.4

2026-09-27

PREAI

Zeinab Dalloul; Ahmad Abboud; Iman Dalloul; Mahmoud Abdelsalam